Schedule 13G ownership disclosure
PLASMATECH BIOPHARMACEUTICAL
Security class unavailable · CUSIP: 72754H109
Event date: 2015-04-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,166,667
- Percent of class
- 5.1700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001011438-15-000177
- Form type
- SC 13G
- Filer
- ABEONA THERAPEUTICS INC.
- CIK
- CIK 318306
- Filed
- May 04, 2015
- Reporting period
- Apr 22, 2015
- Description
- Schedule 13G beneficial ownership